传染性非典型肺炎腹泻的临床分析

Clinical analysis of patients with atypical pneumonia and diarrhea

目的 分析总结传染性非典型肺炎 (SARS)腹泻的临床表现及药物治疗。方法 对 2 2 9例SARS患者的临床资料进行回顾性分析。分为三组 :A组为发病 2周内发生腹泻者 ,B组为发病 2周后发生腹泻者 ,C组为无腹泻发生。结果 A组腹泻时CD4降低比例 (72 .73% )高于B组 (2 3.0 8% ) ,P <0 .0 5。B组 (6 5 .2 2 % )头孢菌素使用比例高于A组 (17.6 5 % )、C组 (4 0 .2 2 % ) ,P <0 .0 5。C组抗病毒药使用比例 (75 .5 4 % )高于B组 (5 2 .17% ) ,P<0 .0 5。结论 SARS患者在发病 2周内腹泻与用药无关。发病 2周后腹泻与使用头孢菌素有关。在SARS的后期 ,抗病毒药物能够抑制SARS病毒的复制 ,对防治腹泻有帮助。

Objective To analyze the clinical representation and therapy of patients with atypical pneumonia and diarrhea.Methods 229 patients with atypical pneumoni were studied retrospectively.Patients were allocated to group A(with diarrhea within two weeks of atypical pneumonia,29 patients),group B(with diarrhea after two weeks of atypical pneumonia,16 patients) and group C(no diarrhea,184 patients).Results Decreased CD 4 at the time of diarrhea of group A was higher than group B.More patients in group B used cephalosporin antibiotics than group A and C.Group C used more anti-viral agents than group B.Conclusions The level of immunity of patients with diarrhea within two weeks of atypical pneumonia is low.Immunity and the use of medicine is not associated with diarrhea.The level of immunity of patients with diarrhea after two weeks of atypical pneumonia is higher than that within two weeks.And immunity is not related to diarrhea.But diarrhea after two weeks of atypical pneumonia is related to the use of cephalosporin.Antiviral is useful in treating diarrhea in atypical pneumonia.